Ginsenoside Re Treatment Attenuates Myocardial Hypoxia/Reoxygenation Injury by Inhibiting HIF-1α Ubiquitination.
Sun H, Ling S, Zhao D, Li J, Li Y, Qu H, Du R, Zhang Y, Xu F, Li Y, Liu C, Zhong G, Liang S, Liu Z, Gao X, Jin X, Li Y, Shi D.
Sun H, et al. Among authors: shi d.
Front Pharmacol. 2020 Sep 9;11:532041. doi: 10.3389/fphar.2020.532041. eCollection 2020.
Front Pharmacol. 2020.
PMID: 33013381
Free PMC article.